Varda Space Industries is moving forward with plans to manufacture pharmaceuticals in space, betting that microgravity conditions will enable production of drugs impossible or inefficient to make on Earth. The startup has signed agreements to begin commercial operations, marking a shift from theoretical space manufacturing to actual orbital production facilities.
Why it matters: Orbital drug manufacturing could unlock new treatments and improve production efficiency for complex pharmaceuticals, representing a convergence of space technology and biotech innovation that could reshape how the industry approaches drug development.